Press release
Epigenetics Drugs and Diagnostic Technologies Market Research and Forecast 2019-2025
An increase in the aging population, as there is a strong correlation between cancer and aging is the factor that drives the growth of the epigenetics drugs and diagnostic technologies market during the forecast period. As per the WHO, it is expected that population over the age of 60 years that would double from 11% in 2000 to 22% in 2050 and people aged 60 and above are more prone to cancer. Thus, countries are advocating early detection of cancer through screening kits such as Epi ProLung and Epi Procolon that are fuelling the growth of the epigenetics drugs and diagnostic technologies market over the forecast period. Cancer epigenetics is a practical resource for scientists that are engaged in testing, development of epigenetic cancer drugs and discovery.Epigenetic modifications have considerable implications for translational science as a biomarker for prognosis and diagnosis. Epigenetic modifications are reversible and epigenetic players are found mutated in different cancers, therefore, they provide attractive therapeutic targets.
To learn more about this report request a free sample copy at https://www.omrglobal.com/request-sample/epigenetics-drugs-and-diagnostic-technologies-market
It seems that boomers may want to keep their competitive edge at work and that the widespread use of smartphone cameras may also be a driving factor. The elderly population is more aware and critical of themselves when they take these photos, and that may drive their attention in looking more youthful, which could ultimately drive the global dermatology devices market.
A full report of Global Epigenetics Drugs and Diagnostic Technologies Marketis available at: https://www.omrglobal.com/industry-reports/epigenetics-drugs-and-diagnostic-technologies-market
High prevalence of cancer and other chronic diseases are some of the key factors expected to boost the market. As per the estimation by National Cancer Institute (NIH),the estimated number of cancer deaths in the U.S. is around 163.5 per 100,000 men and women per year. Moreover, the International Cancer Genome Consortium (ICGC) is mainly focused on obtaining epigenomic changes, genomic description and transcriptomic changes in different types of cancers. The Encyclopedia of DNA Elements (ENCODE) project was launched by the US national human genome research institute with the aim to identify all the human genome sequence elements.
The epigenetic mechanisms in the initiation and development of cancers, that they are including DNA methylation, histone modifications, nucleosomes changes, non-coding RNAs. Epigenetic mechanisms are widely involved in human diseases. The reversible nature of epigenetic changes has led to the emergence of novel epigenetic therapeutic approaches. Epigenetics is defined by inherited somatic changes that are not related to changes in the DNA sequence. So, the epigenetic outlook of a cell is determined by the status of DNA methylation, histones covalent modifications, chromatin structure, and non-coding RNAs and networking with each other.
Global Epigenetics Drugs and Diagnostic Technologies Market- Segmentation
By Type
o Histone Deacetylase (HDAC) Inhibitors
o DNA Methyltransferase (DNMT) Inhibitors
By Product
o Reagents
o Kits
o Instruments
o Enzymes
o Services
By Application
o Cancer Disease
o Inflammatory Diseases
o Infectious Diseases
o Cardiovascular Diseases
o Metabolic Diseases
o Other
For more customized data, request for report customization @ https://www.omrglobal.com/report-customization/epigenetics-drugs-and-diagnostic-technologies-market
Global Epigenetics Drugs and Diagnostic Technologies Market - Segment by Region
North America
o United States
o Canada
Europe
o Germany
o UK
o France
o Spain
o Italy
o Rest of Europe
Asia-Pacific
o China
o Japan
o India
o Rest of Asia-Pacific
Rest of the World
o Latin America
o Middle East & Africa
Company Profiles
o 4SC AG
o AbbVie, Inc.
o Abcam plc
o Aurobindo Pharma USA, Inc.
o Celgene Corp.
o CellCentric, Ltd.
o Celleron Therapeutics, Ltd.
o Eisai, Inc.
o EpiGentek Group, Inc.
o Epizyme, Inc.
o Illumina, Inc.
o MDxHealth SA
o Merck KGaA
o Novartis AG
o Oncolys BioPharma, Inc.
o Otsuka Pharmaceutical Co., Ltd.
o Promega Corp.
o Syndax Pharmaceuticals, Inc.
o Viracta Therapeutics, Inc.
o Zymo Research Corp.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +1 646-755-7667, +91 7803040404
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epigenetics Drugs and Diagnostic Technologies Market Research and Forecast 2019-2025 here
News-ID: 2023951 • Views: …
More Releases from Orion Market Research
Hair Accessories Market Poised for Strong Growth Driven by Gen Z Trends and Sust …
Hair accessories market was valued at $23.8 billion in 2024 and is projected to reach $55.2 billion in 2035, growing at a CAGR of 8.2% during the forecast period (2025-2035). Generation Z, with significant disposable income, is transforming the hair accessories category in a major way. Their close connection to trends creates a unique feeling of urgency to self-express through fashion, such as clips, scrunchies, and barrettes. It has become…
Railway Management System Market Size Analysis, Competitive Insights, Leading Pl …
Railway System (or Railway Management System) market was valued at approximately USD 28.28 billion, and it is expected to reach about USD 45.19 billion by 2033, growing at a CAGR of around 4.8% from 2024 to 2033.
Railway Management System Market Overview
The Railway Management System market includes technologies and systems used to plan, monitor, and manage railway operations-everything from traffic and signaling systems to asset and maintenance management, passenger information,…
Monocalcium Phosphate Market Size Analysis, Competitive Insights, Leading Player …
Monocalcium Phosphate market was valued at about USD 4.2 billion, and it is anticipated to reach around USD 6.9 billion by 2033, growing at a CAGR of approximately 5% from 2023 to 2033.
Monocalcium Phosphate Market Overview
Monocalcium phosphate (MCP) is a calcium-phosphorus compound widely used in animal feed, fertilizers, and also in food and beverage applications (for example as leavening agent or acidity regulator), due to its solubility and bioavailability. The…
Automotive Lubricants Market Size Analysis, Competitive Insights, Leading Player …
Automotive Lubricants Market was valued at approximately USD 70.44 billion. By 2033, it is expected to reach around USD 107.09 billion, growing at a CAGR of about 3.3% from 2025 to 2033.
Automotive Lubricants Market Overview
The automotive lubricants market consists of products like engine oils, gear oils, greases, hydraulic fluids, and transmission fluids that reduce friction, wear and tear, and improve efficiency and lifespan of vehicle components. Demand is driven by…
More Releases for Epi
Consumer Electronics Adoption Fuels The Silicon Epi Wafer Market: Core Growth En …
Stay ahead with our updated market reports featuring the latest on tariffs, trade flows, and supply chain transformations.
What Will the Silicon EPI Wafer Industry Market Size Be by 2025?
Over recent years, the market size for silicon EPI wafers has seen considerable growth. Predictions indicate an increase from $1.8 billion in 2024 to $1.92 billion in 2025, representing a compound annual growth rate (CAGR) of 6.8%. Factors contributing to this historical…
Evolving Market Trends In The Silicon EPI Wafer Industry: Next-Generation Silico …
The Silicon EPI Wafer Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Silicon EPI Wafer Market Size During the Forecast Period?
In recent times, the silicon EPI wafer market has witnessed substantial growth. The market size, which stood at $1.8 billion in…
Leading Growth Driver in the Silicon EPI Wafer Market in 2025: Consumer Electron …
What industry-specific factors are fueling the growth of the silicon epi wafer market?
The silicon EPI wafer market is expected to experience significant growth due to the increased use of consumer electronics products. Consumer electronics (CE) refers to electronic devices specifically designed for everyday use by consumers for non-commercial or professional purposes. Silicon wafers, which are semiconductors, are used in the manufacture of microchips and chips for these electronic devices. For…
EPI Invests $1 Million USD in the EPI Data Center Futurist Scholarship Program
Singapore (15 June 2023) - EPI, the global leader in data center training, audit & certification, is proud to announce the launch of the EPI Data Center Futurist Scholarship program, accompanied by a significant investment of one (1) million US-Dollar. This transformative initiative aims to provide aspiring professionals with the resources and support they need to acquire the specialized knowledge and skills necessary for success in the dynamic data…
Epi Wafer Market to Surpass Valuation of US$ 5.8 Bn by 2030 with Rising Demand f …
The global Epi Wafer market is estimated to attain a valuation of US$ 5.8 billion by the end of 2031, states a study by Transparency Market Research (TMR). Besides, the report notes that the market is prognosticated to expand at a CAGR of 6% during the forecast period, 2021-2031.
The key objective of the TMR report is to offer a complete assessment of the global market including major leading stakeholders of…
Exocrine Pancreatic Insufficiency (EPI) Therapeutics- Pipeline Analysis
Exocrine pancreatic insufficiency (EPI) is the inability of pancreas to produce enough enzymes for the proper breakdown and absorption of nutrients. The common causes of EPI are damage to pancreas, inflammation of pancreas, pancreatic surgery, and inherited disorders like Crohn’s disease and celiac disease.
Download the sample report at: https://www.pharmaproff.com/request-sample/1024
Some symptoms observed during EPI are pain or tenderness in belly, bad-smelling bowel movements, gas, diarrhea and feeling of fullness. EPI…
